Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Remogliflozin Etabonate 100mg + Vildagliptin 50mg
You Searched
Sgltr V 100/50mg Tablet 10s
₹180.3
Our Recommendation
Remo V 100/50mg Tablet 10s
2,974+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
In Treatment of Type 2 diabetes mellitus Sgltr-V Tablet helps control high blood glucose (sugar) levels. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. It also helps reduce the risk of any heart disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Follow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Sgltr-V Tablet can be taken it with or without food, although it's advisable to take it consistently at the same time.
Sgltr-V Tablet is a combination of two anti-diabetic medicines: Remogliflozin Etabonate and Vildagliptin. Remogliflozin Etabonate works by removing excess sugar from your body through urine. Vildagliptin works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces the fasting and post meal sugar levels.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Sgltr-V Tablet .
Seek medical advice from your doctor: Information regarding the use of Sgltr-V Tablet during pregnancy is not available. Doctor consultation is advised.
Seek medical advice from your doctor: Information regarding the use of Sgltr-V Tablet during breastfeeding is not available. Doctor consultation is advised.
Seek medical advice from your doctor: It is not known whether Sgltr-V Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Caution Advised: Sgltr-V Tablet should be used with caution in patients with kidney disease. Dose adjustment of Sgltr-V Tablet may be needed. Doctor consultation is advised.
Caution Advised: Sgltr-V Tablet should be used with caution in patients with liver disease. Dose adjustment of Sgltr-V Tablet may be needed. Doctor consultation is advised.
If a dose of Sgltr-V Tablet is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
208, Okhla Industrial Estate, Phase III, New Delhi - 110020
Glenmark Pharmaceuticals Ltd. Press Release: Glenmark becomes the first company to launch Remogliflozin + Vildagliptin fixed dose combination, at an affordable price for adults with Type 2 Diabetes in India (25 May 2021)
Remogliflozin etabonate + Vildagliptin (08 Feb. 2022)
Remogliflozin Etabonate and Vildagliptin (28th Sept. 2023)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.